Cargando…
Retinoic Acid-Containing Liposomes for the Induction of Antigen-Specific Regulatory T Cells as a Treatment for Autoimmune Diseases
The current treatment of autoimmune and chronic inflammatory diseases entails systemic immune suppression, which is associated with increased susceptibility to infections. To restore immune tolerance and reduce systemic side effects, a targeted approach using tolerogenic dendritic cells (tolDCs) is...
Autores principales: | ter Braake, Daniëlle, Benne, Naomi, Lau, Chun Yin Jerry, Mastrobattista, Enrico, Broere, Femke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8620283/ https://www.ncbi.nlm.nih.gov/pubmed/34834364 http://dx.doi.org/10.3390/pharmaceutics13111949 |
Ejemplares similares
-
Nanoparticles for Inducing Antigen-Specific T Cell Tolerance in Autoimmune Diseases
por: Benne, Naomi, et al.
Publicado: (2022) -
Antigen-expressing immunostimulatory liposomes as a genetically programmable synthetic vaccine
por: Amidi, Maryam, et al.
Publicado: (2010) -
mRNA Polyplexes with Post-Conjugated GALA Peptides
Efficiently Target, Transfect, and Activate Antigen Presenting Cells
por: Lou, Bo, et al.
Publicado: (2018) -
Induction of Antigen-Specific Tolerance in Autoimmune Diabetes with Nanoparticles Containing Hybrid Insulin Peptides
por: DiLisio, James E., et al.
Publicado: (2021) -
In Vivo Induction of Functionally Suppressive Induced Regulatory T Cells from CD4(+)CD25(-) T Cells Using an Hsp70 Peptide
por: van Herwijnen, Martijn J. C., et al.
Publicado: (2015)